Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1996 | 03-1995 | 03-1994 | 03-1993 | 03-1992 | |
| Sales | 227,128 | 235,145 | 221,286 | 180,467 | 166,856 |
| Cost of Goods | 205,727 | 208,408 | 196,870 | 160,289 | 148,689 |
| Gross Profit | 21,401 | 26,737 | 24,416 | 20,178 | 18,167 |
| Operating Expenses | 0 | 13,773 | 13,079 | 12,766 | 10,612 |
| Operating Income | 21,401 | 12,964 | 11,337 | 7,412 | 7,555 |
| Interest Expense | 2,918 | 2,956 | 3,707 | 2,997 | 3,576 |
| Other Income | -13,743 | 616 | -1,022 | -903 | -1,338 |
| Pre-tax Income | 4,740 | 10,624 | 6,608 | 3,512 | 2,641 |
| Income Tax | 1,685 | 3,698 | 2,530 | 1,305 | 306 |
| Net Income Continuous | 3,055 | 6,926 | 4,078 | 3,623 | 2,335 |
| Net Income Discontinuous | 0 | 0 | -10,956 | 0 | 0 |
| Net Income | $3,055 | $6,926 | $-6,878 | $2,207 | $2,335 |
| EPS Basic Total Ops | 0.43 | 0.96 | -1.27 | 0.52 | 0.45 |
| EPS Basic Continuous Ops | 0.43 | 0.96 | 0.56 | 0.70 | 0.45 |
| EPS Basic Discontinuous Ops | N/A | N/A | -1.51 | N/A | N/A |
| EPS Diluted Total Ops | 0.43 | 0.96 | -1.27 | 0.52 | 0.45 |
| EPS Diluted Continuous Ops | 0.43 | 0.96 | 0.56 | 0.70 | 0.45 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -1.51 | N/A | N/A |
| EBITDA(a) | $21,401 | $15,307 | $13,877 | $9,970 | $9,832 |